X

Pharmaceutical manufacturing

Hikal Limited reports Q3 FY26 loss after exceptional charges; interim dividend declared

Hikal Limited (NSE: HIKAL, BSE: 524735) reported a loss for the quarter ended Dec. 31, 2025, after booking exceptional charges…

Amanta Healthcare Limited reports steady Q3 FY26 growth; 9M profit rises on margin expansion and deleveraging

Amanta Healthcare Limited (NSE: AMANTA, BSE: 544502) reported steady revenue growth and improved profitability for the quarter and nine months…